Skip to main content
HRMY logo

HRMY · Harmony Biosciences Holdings, Inc. · Documents

Track HRMY — free
Market Cap
$1.94B
Shares
58.72M
Volume · Nov 17 607.35K Avg daily vol (3M) 1M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Oct 29
Quarterly report 10-Q FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $186.04M ▲ 16.1% Net income $46.09M ▲ 19.8% Diluted EPS $0.79 ▲ 25.4%
Aug 6
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $172.81M ▲ 28.8% Net income $11.59M ▼ 66.2% Diluted EPS $0.20 ▼ 64.3%
Apr 30
Quarterly report 10-Q FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $154.62M ▲ 29.8% Net income $38.33M ▲ 30.0% Diluted EPS $0.67 ▲ 39.6%
Feb 22
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $582.02M ▲ 32.9% Net income $128.85M ▼ 29.0% Diluted EPS $2.13 ▼ 28.3%
2023
Oct 31
Quarterly report 10-Q FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $160.27M ▲ 36.7% Net income $38.46M ▼ 56.3% Diluted EPS $0.63 ▼ 56.3%
Aug 1
Quarterly report 10-Q FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $134.22M ▲ 25.4% Net income $34.3M ▲ 45.8% Diluted EPS $0.56 ▲ 43.6%
May 2
Quarterly report 10-Q FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $119.13M ▲ 39.6% Net income $29.49M ▲ 37.2% Diluted EPS $0.48 ▲ 37.1%
Showing 51–100 of 160 documents
Key facts CIK 1802665 CUSIP 413197104 13F (30d) 362 filings 343 filers Visit website Investor relations